Atlanta Consulting Group Advisors’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,876	Closed	-$700K	–	190
2024 Q3	$700K	Buy	5,876 +4,037	+220%	+$481K	0.17%	102
2024 Q2	$262K	Sell	1,839 -2,123	-54%	-$303K	0.06%	98
2024 Q1	$509K	Buy	+3,962	New	+$509K	0.18%	71